Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVO-HYDROXYZIN | 50MG | CAPSULE | Actual shortage | 2017-03-13 | 2020-02-13 | 1017 |
| NOVO-HYDROXYZIN | 25MG | CAPSULE | Actual shortage | 2017-03-13 | 2017-10-05 | 1013 |
| NOVO-HYDROXYZIN | 10MG | CAPSULE | Actual shortage | 2017-03-10 | 2017-10-05 | 159 |
| NOVO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2017-03-14 | 2017-04-25 | 2278 |
| NOVO-PROFEN | 400MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42644 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2025-10-01 | 2025-10-01 | 268159 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2021-03-11 | 2021-04-29 | 135561 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124959 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-10-11 | 2024-11-08 | 240046 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-10-17 | 2025-01-30 | 240525 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2024-11-28 | 2025-05-30 | 244081 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166975 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-17 | 166969 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2025-07-29 | 2025-08-29 | 263746 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT | Resolved | 2022-03-04 | 2022-03-24 | 156070 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2025-09-19 | 2025-12-18 | 267502 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2025-12-18 | 2025-12-18 | 274590 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2025-12-18 | 2025-12-18 | 274595 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2025-01-09 | 2025-11-06 | 247309 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |